BOK Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $724K | Sell |
10,748
-5,298
| -33% | -$353K | 0.01% | 494 |
|
|
2026
Q1 | $1.01M | Sell |
16,046
-19,268
| -55% | -$1.34M | 0.02% | 426 |
|
|
2025
Q4 | $2.34M | Buy |
35,314
+22,505
| +176% | +$1.45M | 0.04% | 298 |
|
|
2025
Q3 | $862K | Sell |
12,809
-254
| -2% | -$20.1K | 0.01% | 467 |
|
|
2025
Q2 | $1.14M | Buy |
13,063
+3,985
| +44% | +$312K | 0.02% | 431 |
|
|
2025
Q1 | $620K | Buy |
9,078
+4,225
| +87% | +$345K | 0.01% | 515 |
|
|
2024
Q4 | $377K | Sell |
4,853
-1,032
| -18% | -$76.4K | 0.01% | 607 |
|
|
2024
Q3 | $387K | Sell |
5,885
-40,295
| -87% | -$3.31M | 0.01% | 611 |
|
|
2024
Q2 | $5.24M | Sell |
46,180
-750
| -2% | -$94.8K | 0.09% | 195 |
|
|
2024
Q1 | $6.47M | Sell |
46,930
-460
| -1% | -$57.8K | 0.12% | 176 |
|
|
2023
Q4 | $5.88M | Buy |
47,390
+8,699
| +22% | +$889K | 0.12% | 177 |
|
|
2023
Q3 | $3.44M | Buy |
38,691
+18,510
| +92% | +$2.09M | 0.08% | 231 |
|
|
2023
Q2 | $2.59M | Buy |
20,181
+12,518
| +163% | +$1.51M | 0.05% | 298 |
|
|
2023
Q1 | $890K | Sell |
7,663
-4,069
| -35% | -$455K | 0.02% | 477 |
|
|
2022
Q4 | $1.33M | Sell |
11,732
-79
| -0.7% | -$8.67K | 0.02% | 449 |
|
|
2022
Q3 | $952K | Buy |
11,811
+407
| +4% | +$34.5K | 0.02% | 511 |
|
|
2022
Q2 | $850K | Sell |
11,404
-3,976
| -26% | -$363K | 0.02% | 560 |
|
|
2022
Q1 | $1.97M | Sell |
15,380
-1,384
| -8% | -$151K | 0.03% | 415 |
|
|
2021
Q4 | $2.25M | Sell |
16,764
-904
| -5% | -$130K | 0.03% | 382 |
|
|
2021
Q3 | $2.42M | Buy |
+17,668
| New | +$2.23M | 0.04% | 354 |
|
|
2021
Q1 | $2.33M | Buy |
25,912
+6,352
| +32% | +$596K | 0.04% | 358 |
|
|
2020
Q4 | $1.81M | Buy |
19,560
+1,620
| +9% | +$145K | 0.03% | 385 |
|
|
2020
Q3 | $1.85M | Buy |
17,940
+1,868
| +12% | +$195K | 0.04% | 339 |
|
|
2020
Q2 | $1.63M | Sell |
16,072
-5,200
| -24% | -$465K | 0.04% | 374 |
|
|
2020
Q1 | $1.43M | Sell |
21,272
-220
| -1% | -$13.7K | 0.04% | 354 |
|
|
2019
Q4 | $1.18M | Sell |
21,492
-684
| -3% | -$32.4K | 0.03% | 478 |
|
|
2019
Q3 | $827K | Sell |
22,176
-668
| -3% | -$26K | 0.02% | 546 |
|
|
2019
Q2 | $856K | Sell |
22,844
-648
| -3% | -$20.4K | 0.02% | 529 |
|
|
2019
Q1 | $699K | Buy |
23,492
+1,028
| +5% | +$36.1K | 0.02% | 585 |
|
|
2018
Q4 | $673K | Sell |
22,464
-1,288
| -5% | -$40.9K | 0.02% | 544 |
|
|
2018
Q3 | $849K | Sell |
23,752
-972
| -4% | -$30.1K | 0.02% | 535 |
|
|
2018
Q2 | $587K | Buy |
24,724
+76
| +0.3% | +$1.61K | 0.02% | 626 |
|
|
2018
Q1 | $457K | Sell |
24,648
-1,116
| -4% | -$16.5K | 0.01% | 662 |
|
|
2017
Q4 | $370K | Buy |
25,764
+8,784
| +52% | +$114K | 0.01% | 743 |
|
|
2017
Q3 | $207K | Buy |
16,980
+1,244
| +8% | +$22K | 0.01% | 870 |
|
|
2017
Q2 | $288K | Buy |
15,736
+892
| +6% | +$16.5K | 0.01% | 764 |
|
|
2017
Q1 | $314K | Sell |
14,844
-8,284
| -36% | -$162K | 0.01% | 758 |
|
|
2016
Q4 | $345K | Buy |
23,128
+8,728
| +61% | +$155K | 0.01% | 723 |
|
|
2016
Q3 | $316K | Buy |
+14,400
| New | +$321K | 0.01% | 746 |
|
Other funds holding DXCM
BOK Financial's DXCM Position: Q2 2026 in Review
BOK Financial reduced its DexCom (DXCM) stake by 33% in Q2 2026, selling an estimated $353K and leaving 10,748 shares worth $724K. The position accounts for 0.01% of the portfolio, ranked #494.
BOK Financial first reported a position in DXCM in Q3 2016 and has held it in 39 quarters since. The position peaked at $6.47M in Q1 2024. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- BOK Financial held 10,748 shares of DexCom worth $724K as of Q2 2026.
- BOK Financial sold 5,298 DexCom shares in Q2 2026, an estimated $353K.
- DexCom made up 0.01% of BOK Financial's portfolio in Q2 2026, its #494 holding.
- BOK Financial first reported a position in DexCom in Q3 2016 and has held it in 39 quarters since.
- BOK Financial's DexCom position peaked at $6.47M in Q1 2024.
- 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.